Skip to main content
A WORLDWIDE ALLERGY COMPANY
A WORLDWIDE ALLERGY COMPANY
Find your location
  • Global
  • Australia
  • Austria
  • Belgium
  • Canada
  • Czech republic
  • France
  • Germany
  • Italy
  • Netherlands
  • Middle East
  • New Zealand
  • Nordics
  • Poland
  • Russia
  • Slovakia
  • Spain
  • Switzerland
  • United Kingdom
  • USA
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
      Governance
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
    • Governance
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
Find your location
  • Global
  • Australia
  • Austria
  • Belgium
  • Canada
  • Czech republic
  • France
  • Germany
  • Italy
  • Netherlands
  • Middle East
  • New Zealand
  • Nordics
  • Poland
  • Russia
  • Slovakia
  • Spain
  • Switzerland
  • United Kingdom
  • USA

Breadcrumb

  1. News center
  2. Press releases
News center

Breadcrumb

  1. News center
  2. Press releases
News center
  • Press releases
  • Publications
News center

Press releases

For matters related to Global communications, please contact:

Catherine Kress 

Head of Communications

Email: communications@stallergenesgreer.com

Tel:  +33 (0)1 55 59 26 05

S'inscrire

Parcourir par année

  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025

2014-11-20 - Collaboration de Stallergenes et ActoGenix

Télécharger

2014-10-23 - Chiffre d'affaires de Stallergenes de 45,7 m€ au T3 2014

Télécharger

2014-07-24 - Revenus et résultats semestriels

Télécharger

2014-07-21 - Stallergenes reforce sa présence en Amérique latine avec l'acquisition d'ALERGO PHARMA S.R.L. en Argentine

Télécharger

2014-05-06 - L’Assemblée Générale Ordinaire et Extraordinaire du 27 mai 2014

Télécharger

2014-04-24 - Stallergenes annonce un CA en hausse de 1,5% au T1 2014

Télécharger

2014-04-02 - Stallergenes annonce l'approbation par la FDA d'Oralair

Télécharger

2014-03-05 - Stallergenes annonce une hausse de 3,5% de ses revenus totaux en...

Télécharger

2014-03-05 - Stallergenes annonce une hausse de 3,5% de ses revenus totaux en...

Télécharger

2014-03-05 - nomination de Christian Chavy en tant que directeur général de S...

Télécharger

2014-02-03 - Résultats positifs de l'étude clinique de phase II/III au Japon...

Télécharger
  • Press releases
  • Publications
© 2025 Stallergenes Greer
    |
  • Site Map
  • |
  • terms & conditions
  • |
  • Modern Slavery Act Statement
  • |
  • Contact
  • Cookie Policy
  • |
  • Personal Data Protection Policy

YOU ARE LEAVING THE STALLERGENESGREER.COM WEBSITE

This link will take you to content that may not be appropriate for UK audiences on a website to which our Privacy Policy does not apply. Stallergenes Greer UK has no control over the contents of these sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them.

Continue

Cookies

Reject and continue

STALLERGENES GREER uses technical cookies essential for the functioning of the site as well as audience measurement cookies. You can accept audience measurement cookies by clicking on “Accept” or reject them by clicking on “Reject and continue”. You can change your mind at any time by clicking on “Cookies Management” and manage your preferences by clicking on “Set your preferences”. For more information, please read our Cookie Policy

Set your preferences

Google Analytics
Track website traffic
Save my preferences
Set your preferences
Accept Save my preferences
Cookies Management